Methacrylic Acid

Methacrylic Acid

SCHEMBL672275

C=C(C)C(=O)[O-].C=C(C)C(=O)[O-].C=C(C)C(=O)[O-].C=C(C)C(=O)[O-].[Mo+4]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.53
CA1 P00915 2/20 0.50
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 2/20 0.40
FAHD1 Q6P587 1/20 0.40
LMNA P02545 2/20 0.36
HSD17B10 Q99714 1/20 0.35
BLM P54132 2/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 1/20 0.33
LDHA P00338 1/20 0.33
KMT2A Q03164 1/20 0.33
THPO P40225 1/20 0.33
FFAR3 O14843 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
ALOX15 P16050 1/20 0.31
PMP22 Q01453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL19384595 0.96 CA4 (0.57) CA4CA1TDP1ALDH1A1FAHD1
Methacrylic Acid SCHEMBL59390 0.96
Methacrylic Acid SCHEMBL10989117 0.92
Methacrylic Acid SCHEMBL50463 0.92
Methacrylic Acid SCHEMBL3145701 0.92 CA4 (0.53) CA4CA1TDP1ALDH1A1FAHD1
Methacrylic Acid SCHEMBL23175214 0.92 CA4 (0.53) CA4CA1TDP1ALDH1A1FAHD1
Methacrylic Acid SCHEMBL10339748 0.92 CA4 (0.53) CA4CA1TDP1ALDH1A1FAHD1
Methacrylic Acid SCHEMBL11614214 0.92 CA4 (0.53) CA4CA1TDP1ALDH1A1FAHD1
Methacrylic Acid SCHEMBL20582675 0.92 CA4 (0.53) CA4CA1TDP1ALDH1A1FAHD1
Methacrylic Acid SCHEMBL6914647 0.92 CA4 (0.53) CA4CA1TDP1ALDH1A1FAHD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2889284-B1 METHOD FOR PRODUCING IRON CARBONATE MITSUBISHI CHEM CORP (JP) 2017-10-11 EP disclosed
US-9540308-B2 Method for producing iron carboxylate MITSUBISHI RAYON CO., LTD. (JP) 2017-01-10 US disclosed
US-20150218080-A1 METHOD FOR PRODUCING IRON CARBOXYLATE MITSUBISHI RAYON CO., LTD. (JP) 2015-08-06 US disclosed
EP-2889284-A1 METHOD FOR PRODUCING IRON CARBONATE Mitsubishi Rayon Co., Ltd. (JP) 2015-07-01 EP disclosed
US-20120252979-A1 Process for Producing Blends of Syndiotactic, 1,2-Polybutadiene and Rubbery Elastomers RADEMACHER CHRISTINE (US) 2012-10-04 US disclosed
US-8203018-B2 Reaction of (meth)acrylic acid and alkylene oxide in the presence of a chromium catalyst; efficient recycling use of a catalyst once used for a reaction to the subsequent reaction; suppression of formation of a biadduct (dialkylene glycol mono(meth)acrylate) as a by-product NIPPON SHOKUBAI CO., LTD. (JP) 2012-06-19 US disclosed
EP-1775279-B1 PROCESSES FOR PRODUCING HYDROXYALKYL (METH)ACRYLATE NIPPON CATALYTIC CHEM IND (JP) 2011-11-30 EP disclosed
US-8067503-B2 Process for producing blends of syndiotactic, 1,2-polybutadiene and rubbery elastomers BRIDGESTONE CORPORATION (JP) 2011-11-29 US disclosed
EP-1371629-B1 Process for the preparation of hydroxyalkyl(meth)acrylate NIPPON CATALYTIC CHEM IND (JP) 2008-12-10 EP disclosed
US-20080154060-A1 Reaction of (meth)acrylic acid and alkylene oxide in the presence of a chromium catalyst; efficient recycling use of a catalyst once used for a reaction to the subsequent reaction; suppression of formation of a biadduct (dialkylene glycol mono(meth)acrylate) as a by-product NIPPON SHOKUBAI CO., LTD. (JP) 2008-06-26 US disclosed
EP-1183283-B1 MOLYBDENUM-BASED CATALYST COMPOSITION FOR POLYMERIZING CONJUGATED DIENES BRIDGESTONE CORP (JP) 2003-06-11 EP disclosed
WO-2003040231-A1 PROCESS FOR PRODUCING BLENDS OF SYNDIOTACTIC 1,2-POLYBUTADIENE AND RUBBERY ELASTOMERS BRIDGESTONE CORPORATION (JP) 2003-05-15 WO disclosed
US-6545107-B2 Reaction product of an molybdenum- containing compound, a silyl phosphonate; and an organoaluminum compound catalyst used for polymerizing conjugated diene monomer BRIDGESTONE CORPORATION (JP) 2003-04-08 US disclosed
US-6528588-B2 Polymerization of 1,3-butadiene in the presence of a catalyst made of a chromium compound, a hydrogen phosphite, an organomagnesium compound, a molybdenum containing compound and an organoaluminum compound BRIDGESTONE CORPORATION (JP) 2003-03-04 US disclosed
US-20020198337-A1 Molydenum-based catalyst composition for producing syndiotactic 1,2-polybutadiene BRIDGESTONE CORP. 2002-12-26 US disclosed
US-20020037967-A1 Process for producing blends of syndiotactic 1,2-polybutadiene and rubbery elastomers with a chromium-based catalyst system BRIDGESTONE CORPORATION (JP) 2002-03-28 US disclosed
EP-1183283-A1 MOLYBDENUM-BASED CATALYST COMPOSITION FOR POLYMERIZING CONJUGATED DIENES BRIDGESTONE CORPORATION (JP) 2002-03-06 EP disclosed
US-6348550-B1 ADDITION POLYMERIZATION OF 1,3-BUTADIENE TO SYNDIOTACTIC 1,2-POLYBUTADIENE USING COORDINATION CATALYST COMPRISING MOLYBDENUM COMPOUND, A HYDROGEN PHOSPHITE, AND MIXTURE OF (NON)STERICALLY HINDERED ORGANOALUMINUM COMPOUNDS BRIDGESTONE CORPORATION (JP) 2002-02-19 US disclosed
US-6303692-B1 PROVIDING MIXTURE OF RUBBER CEMENT AND 1,3-BUTADIENE; POLYMERIZING INTO SYNDIOTACTIC 1,2-POLYBUTADIENE BY USING CATALYST FORMULATION COMPRISING MOLYBDENUM COMPOUND, HYDROGEN PHOSPHITE COMPOUND AND ORGANOALUMINUM COMPOUND BRIDGESTONE CORPORATION (JP) 2001-10-16 US disclosed
WO-2000075201-A1 MOLYBDENUM-BASED CATALYST COMPOSITION FOR POLYMERIZING CONJUGATED DIENES BRIDGESTONE CORPORATION (JP) 2000-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218080-A1 METHOD FOR PRODUCING IRON CARBOXYLATE FECH, CA2, CA5B CA4 9/4885CA1 8/4885TDP1 4845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.